India’s cancer care is shifting as cheaper immunotherapy drugs developed in China arrive through Indian partnerships. Oncologists say these options are expanding access for patients who cannot afford pricier Western medicines. The result, doctors claim, is less financial strain and fewer cases where cancer treatment drives families into severe debt, alongside improving affordability of sustained care.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
